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The genetic diversity of 134 serogroup X Neisseria meningitis isolates from Africa, Europe, and North
America was analyzed by multilocus sequence typing and pulsed-field gel electrophoresis. Although most
European and American isolates were highly diverse, one clonal grouping was identified in sporadic dis-
ease and carrier strains isolated over the last 2 decades in the United Kingdom, the Netherlands, Ger-
many, and the United States. In contrast to the diversity in the European and American isolates, most
carrier and disease isolates recovered during the last 30 years in countries in the African meningitis belt
belonged to a second clonal grouping. During the last decade, these bacteria have caused meningitis out-
breaks in Niger and Ghana. These results support the development of a comprehensive conjugate vaccine
that would include serogroup X polysaccharide.
acterial meningitis due to Neisseria meningitidis (menin-
gococcus) causes epidemics in Africa usually associated
with serogroup A meningococci. Sporadic cases, outbreaks,
and hyperendemic disease in Europe and the United States are
usually caused by serogroups B and C (1). Occasionally, how-
ever, endemic disease and outbreaks are caused by bacteria
belonging to other serogroups, including W135, Y, and X.
Serogroup X N. meningitidis was described in the 1960s (2,3),
and serogroup X meningitis has been observed in North Amer-
ica (4), Europe (5,6), Australia (7), and Africa (8,9). Sero-
group X outbreaks have been reported in Niger (10,11) and
Ghana (12). In some cases, serogroup X disease has been asso-
ciated with a deficiency of particular complement components
(13,14) or with AIDS (15).
Asymptomatic nasopharyngeal carriage of N. meningitidis
is common, and in only a small percentage of colonized per-
sons do the bacteria invade the bloodstream and cerebrospinal
fluid to cause disease. Meningococcal populations are highly
diverse, and lineages of meningococci with increased capacity
to cause invasive disease are thought to arise periodically and
spread, sometimes globally (16). Relatively few of these
hyperinvasive lineages or clonal groupings are responsible for
most meningococcal disease worldwide (17). These clonal
groupings diversify during spread (18,19), primarily as a result
of frequent horizontal genetic exchange (19-21). However,
many variants are isolated only rarely or from a single country
and are not transmitted further because of bottlenecks associ-
ated with geographic spread and competition (19,22). The
population structure of N. meningitidis is effectively panmictic
as a result of frequent horizontal genetic exchange  (23), but
that of some groupings, such as epidemic serogroup A menin-
gococci, is largely clonal (24). The population structure of
serogroup X meningococci has not yet been investigated in
detail. 
After an epidemic of serogroup A disease in 1997-1998 in
northern Ghana (9), we conducted a longitudinal carriage
study to investigate the dynamics of meningococcal carriage
during an interepidemic period (12). We observed a sharp
increase in nasopharyngeal carriage of serogroup X meningo-
cocci by healthy persons, accompanied by several cases of
serogroup X meningitis. To investigate the phylogenetic rela-
tionships of these bacteria, we compared the isolates from
Ghana with other serogroup X meningococci isolated during
recent decades in Africa, Europe, and North America.
Materials and Methods
Bacterial Strains
We analyzed 134 N. meningitidis isolates of serogroup X
by pulsed-field gel electrophoresis (PFGE) (130 isolates) or
multilocus sequence typing (MLST) (41 isolates). Of these
bacteria, 102 were isolated in Africa from 1970 to 2000: from
meningitis patients (9 isolates) and healthy carriers (70 iso-
lates) in Ghana, 1998-2000; from healthy carriers in Mali in
1970 (9 isolates) and 1990-91 (4 isolates); and from patients in
Chad (1995, 1 isolate), Niger (1997-1998, 4 isolates), and
Burkina Faso (1996-1998, 5 isolates). Six isolates were not
tested serologically; the other 96 were NT:P1.5.
In addition, 32 serogroup X strains isolated from 1988 to
2000 in the United Kingdom (22 isolates), Germany (3 iso-
lates), United  States (4 isolates), France (1 isolate), Norway (1
isolate), and the Netherlands (1 isolate) were included in the
analysis. The 26 strains subjected to further testing had diverse
serotypes (2b, 4, 4/21, 14, 16, 21, 22) and serosubtypes (non-
subtypable [NST], P1.5, P1.5,10, P1.7, P1.12, P1.14, P1.15,
P1.16) in various combinations. 
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Molecular Typing of Bacteria
PFGE was done by digesting chromosomal DNA prepared
in agarose blocks with NheI and SpeI as described (22), and
MLST by sequencing gene fragments of abcZ,  adk,  aroE,
fumC, gdh, pdhC, and pgm, also as described (16; http://www/
mlst.net). The detailed MLST results and sources of isolates
have been deposited in a public database (http://
www.mlst.net). Additional MLST data for 31 isolates in 30
sequence types were obtained with permission from http://
www.mlst.net. 
Data Analysis
A neighbor-joining tree was constructed by using the num-
bers of MLST allele differences with Bionumerics 2.0 (25).
Results
PFGE with two discriminatory rare-cutting enzymes (NheI
and SpeI) was used to identify groups of closely related strains
in 134 isolates of serogroup X N. meningitidis from countries
in Africa, Europe, and North America. All but 3 of 102 iso-
lates from Africa had similar PFGE patterns (Figure 1, clonal
grouping X-I). In contrast, 19 of 32 isolates from Europe and
North America had distinct PFGE patterns (Figure 2) that dif-
fered from those of the African isolates. However, among the
latter 32 strains, similar PFGE patterns were observed for 13
isolates from the United Kingdom, Germany, the Netherlands,
and the United States (Figure 2, clonal grouping X-II).
Forty-one isolates, each representing a distinct PFGE pat-
tern, were analyzed by MLST. For bacteria from which multi-
ple isolates with a similar PFGE pattern had been detected, we
tested at least one representative from each year and country of
isolation. Together with other data in the MLST WEB site
(http://www.mlst.net), 39 distinct sequence types (STs) have
been found in 50 serogroup X meningococci. The general
structure of a neighbor-joining tree of allelic differences
resembles a bush, with little phylogenetic structure (Figure 3).
However, isolates with similar PFGE patterns were assigned to
closely related STs. All 29 clonal grouping X-I isolates ana-
lyzed by MLST were in STs ST181, ST182, or ST751 (Figure
3), which differ by one to three of the seven gene fragments
(Table). Similarly, all five clonal grouping X-II isolates were
in STs 24 and 750, which differ by one of the seven gene frag-
ments (Table). The three unusual African isolates (strain desig-
nations D87, D91, and D93) were in ST188, which is very
distinct from STs of clonal grouping X-I (Figure 3). These
results show that numerous serogroup X isolates from Africa
and nearly half the serogroup X isolates from Europe and
North America belong to two clonal groupings, while other
serogroup X isolates from Europe or North America are quite
diverse.
Serologic Results
African isolates of clonal grouping X-I were NT:P1.5. The
11 North American and European isolates of clonal grouping
X-II for which serologic data were available were 21:P1.16.
Diverse serotype and serosubtype patterns were found for the
other isolates from North America and Europe
The PFGE patterns distinguished two finer groups (Ia and
Ib) in clonal grouping X-I, which differ consistently in four
NheI and three SpeI fragments (Figure 1). All 14 group Ia
strains tested were either ST181 or ST182, which differ at one
of the seven gene fragments (Table). All 15 group Ib strains
tested were ST751, which differs from ST181 and ST182 at
two to three loci (Table). Group Ia included 10 isolates from
Mali (1970-1990), 4 isolates from Niger (1997-1998), and the
sole isolate from Chad (1995), as well as one of 79 isolates
Figure 1. Two groups of pulsed-field gel elec-
trophoresis patterns among NheI- and SpeI-
digested chromosomal DNA from selected
serogroup X Neisseria meningitidis strains
isolated in Africa. Lane: strain: 1: D93
(ST188); 2: 1970; 3: 3187; 4: 3529; 5: D5; 6:
LNP13407; 7: LNP14964; 8: LNP15040; 9:
97013; 10: 97014; 11: Z9413; 12: LNP14297;
13: LNP15061; 14: BF2/97; 15: BF5/97; 16:
BF1/98; 17: Z7091; 18: Z8336; 19: Z9291.
Molecular weight markers were loaded in the
flanking lanes as indicated (L: low-range
marker; M: midrange marker); their molecular
weights are indicated at the left. Characteristic
band differences are indicated on the right.RESEARCH
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from Ghana (2000). All five isolates from Burkina Faso
(1996-1998) and 78 of 79 isolates from Ghana (1998-2000)
were in group Ib. 
Discussion
The general population structure of N. meningitidis is pan-
mictic as a result of the frequent import of alleles from unre-
lated neisseriae (20,23). Furthermore, several MLST studies
have demonstrated that meningococci from healthy carriers
are highly diverse (16,26). Phylogenetic trees of different
housekeeping genes from N. meningitidis are no more congru-
ent with each other than with random trees (27). Our results
for sequence typing of housekeeping genes of serogroup X
meningococci also fit this pattern. Phylogenetic analysis of
allele differences resulted in a bushlike tree that does not seem
to contain any deep phylogenetic information. However, two
clonal groupings were found in this otherwise panmictic group
of bacteria. The same isolates were assigned to both clonal
groupings by two independent methods, MLST and PFGE,
indicating that these assignments reflect real genetic relation-
ships and do not depend on the methods used. 
Similar concordant genetic relationships were discerned in
epidemic serogroup A N. meningitidis by multilocus enzyme
electrophoresis (MLEE), random amplification of polymor-
phic DNA (RAPD), and MLST; population genetic analyses
confirmed that the population structure of these bacteria is
clonal (28). Concordant groupings were also discerned by
MLEE and MLST among the so-called hypervirulent sero-
group B and C isolates of the ET-5 complex, ET-37 complex,
lineage III, and cluster A4 (16). Although their apparent
clonality may reflect an epidemic population structure (23),
this possibility has been excluded for epidemic serogroup A
meningococci (28). Therefore, multiple clonal groupings exist
in  N. meningitidis, even though the population structure of
most of the species is panmictic.
Figure 3. Neighbor-joining phenogram of allelic identities in 39 multilo-
cus sequence typing (MLST) sequence types from serogroup X Neis-
seria meningitidis. Numbers at nodes are the percentages of 1,000
bootstrap replicates in which these nodes appeared. Only nodes with
percentages >50% were included. The two boxes indicate clonal group-
ings that were detected by MLST or pulsed-field gel electrophoresis.
Figure 2. Pulsed-field gel electrophoresis patterns
of  NheI-digested chromosomal DNA of selected
serogroup X Neisseria meningitidis isolates from
Europe and the United States, plus a prototype
isolate from Ghana (lane 13). Lane: strain: 1: E26;
2: X4571; 3: X4890; 4: M2526; 5: M4222; 6:
M3772; 7: LNP17351; 8: J88-603; 9: K89-1395;
10: L92-1413; 11: M98-253172; 12: M00-240465;
13: Z9291; 14: M98-252848; 15: M98-252718; 16:
M99-240899; 17: X5967; 18: 860060; 19: M4370.Emerging Infectious Diseases  •  Vol. 8, No. 5, May 2002 465
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The population structure of subgroup III serogroup A men-
ingococci seems to represent continual, sequential replacement
of fit genotypes by related variants during periods of several
years to decades (19). In subgroup III, nine genoclouds, each
consisting of a frequent genotype plus its rarer, less fit vari-
ants, have been identified during 3 decades of pandemic
spread. Our PFGE data for clonal grouping I of serogroup X
suggest that clonal grouping X-I also has a genocloud struc-
ture. Two sets of PFGE variants (group Ia and Ib), which
might each represent a genocloud, were detected in different
countries (Mali, Chad, and Niger; and Burkina Faso and
Ghana, respectively). Additional analyses of polymorphic
genes are necessary to clarify the uniformity of these groups
and to test the similarity of their population structure com-
pared with that of subgroup III. 
Both serogroup X clonal groupings described here were
isolated over decades, on multiple occasions, and from diverse
locations. Clonal grouping X-I (1970-2000) was isolated from
different countries in West Africa, and clonal grouping X-II
(1986-1999) was isolated from Europe and North America.
For clonal grouping X-I in Ghana, the disease rate in healthy
carriers was estimated to be 3/10,000 (12). Clonal grouping X-
1 is thus of considerably lower virulence than serogroup B ET-
5 complex bacteria (disease/carrier rate of 2,100/10,000 [29])
or serogroup A subgroup III bacteria during a postepidemic
period in a vaccinated population (100/10,000 [9]). 
The relationship between bacterial fitness and clonality has
not yet been investigated extensively in natural isolates. Varia-
tion in virulence between bacterial genotypes leads to more
uniformity in disease isolates than in carriage organism in
Streptococcus pneumoniae (30) and Staphylococcus aureus
(31). However, our data suggest that the clonal structure of
certain meningococcal genotypes need not reflect virulence
but rather is associated with genotypes that are particularly fit
at colonizing the nasopharynx and spreading from person to
person. 
Although clonal grouping X-I bacteria are less virulent
than serogroup A and B meningococci, they are still patho-
genic. Most strains described here were isolated from asymp-
tomatic carriers or patients with rare endemic cases. However,
group Ia caused a meningitis outbreak with >60 cases in 1997
in Niger (11). Group Ib caused a smaller outbreak in 2000 in
Ghana (12). These results suggest that X-I meningococci may
even be capable of causing epidemics. Meningococci are natu-
rally transformable, and horizontal DNA transfer is frequent in
these bacteria (20-22). Meningococcal carriage is usually low
in interepidemic periods in Africa (1,12,32,33), offering less
opportunity for horizontal genetic exchange, which could
account for the low genetic variability in serogroup X menin-
gococci in Africa. 
For more than a decade, many countries in the African
meningitis belt have vaccinated extensively with A/C polysac-
charide vaccines (34). Recently, mass vaccination with conju-
gated serogroup C vaccines has been implemented in the
United Kingdom, and strong initial protection has been
reported (35). However, if effective, these vaccines may well
select for the spread of bacteria for which they are not protec-
tive (36), including unusual causes of disease such as sero-
groups Y, W135, and X. Capsule switching due to DNA
transformation has been documented (37,38), and effective
vaccination against serogroups A and C may select for capsule
switch variants of fit genotypes expressing a capsular polysac-
charide not included in the vaccination program. The recent
outbreaks after the 2000 Hajj pilgrimage, caused by W135 ET-
37 complex meningococci (39,40), may reflect exactly such
selection. These findings support the development of compre-
hensive conjugate vaccines that include capsular polysaccha-
rides from formerly rare causes of disease such as serogroup X.
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Table. Multilocus sequence typing results of two serogroup X Neisseria meningitidis clonal groupings
ST
Allele numbers
Country (no. of isolates) Yr AbcZ Adk aroE FumC gdh pdhC Pgm
24 2 5 2 7 15 20 5 Netherlands (1), United States (1) 1986, 1993
750 2 5 2 9 15 20 5 United Kingdom (2), Germany (1) 1998-1999
181 10 3 15 7 5 41 31 Mali (6), Chad (1), Niger (2), Ghana (1) 1970-2000
182 10 3 15 26 5 41 31 Mali (4) 1970
751 10 3 15 7 8 41 6 Burkina Faso (3), Ghana (12) 1996-2000RESEARCH
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genetic characterization of Neisseria meningitidis and Mycobacte-
rium tuberculosis.
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